These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25855582)

  • 101. Obesity as a cause of hepatocellular carcinoma.
    Kew MC
    Ann Hepatol; 2015; 14(3):299-303. PubMed ID: 25864208
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.
    Wong RJ; Ahmed A; Gish RG
    Clin Liver Dis; 2015 May; 19(2):309-23. PubMed ID: 25921665
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Longitudinal Assessment of Three Serum Biomarkers to Detect Very Early-Stage Hepatocellular Carcinoma.
    Choi J; Kim GA; Han S; Lee W; Chun S; Lim YS
    Hepatology; 2019 May; 69(5):1983-1994. PubMed ID: 30153338
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Biomarkers for the early diagnosis of hepatocellular carcinoma.
    Tsuchiya N; Sawada Y; Endo I; Saito K; Uemura Y; Nakatsura T
    World J Gastroenterol; 2015 Oct; 21(37):10573-83. PubMed ID: 26457017
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Kidney-type glutaminase is a biomarker for the diagnosis and prognosis of hepatocellular carcinoma: a prospective study.
    Zhang L; Su K; Liu Q; Li B; Wang Y; Cheng C; Li Y; Xu C; Chen J; Wu H; Zhu M; Mai X; Cao Y; Peng J; Yue Y; Ding Y; Yu D
    BMC Cancer; 2023 Nov; 23(1):1081. PubMed ID: 37946141
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Levels of PIVKA-II and alpha-fetoprotein in unresectable hepatocellular carcinoma compared to healthy controls and predictive values of both markers with radiological responses after loco-regional interventions.
    Hamzah N; Kassim NK; Omar J; Abdullah MS; Lee YY
    PeerJ; 2023; 11():e15988. PubMed ID: 37780370
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Diagnostic performance of circulating tumor DNA as a minimally invasive biomarker for hepatocellular carcinoma: a systematic review and meta-analysis.
    Li JJ; Lv Y; Ji H
    PeerJ; 2022; 10():e14303. PubMed ID: 36348665
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Molecularly imprinted polymers outperform lectin counterparts and enable more precise cancer diagnosis.
    Pang J; Li P; He H; Xu S; Liu Z
    Chem Sci; 2022 Apr; 13(16):4589-4597. PubMed ID: 35656127
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Vitamin K-Dependent Protein Activation: Normal Gamma-Glutamyl Carboxylation and Disruption in Disease.
    Berkner KL; Runge KW
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628569
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Using circulating tumor DNA as a novel biomarker to screen and diagnose hepatocellular carcinoma: A systematic review and meta-analysis.
    Zhang Z; Chen P; Xie H; Cao P
    Cancer Med; 2020 Feb; 9(4):1349-1364. PubMed ID: 31876977
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Integrin α6-Targeted Magnetic Resonance Imaging of Hepatocellular Carcinoma in Mice.
    Zhang Y; Zhao J; Cai J; Ye JC; Xiao YT; Mei Y; Zeng MS; Xie CM; Jiang Y; Feng GK
    Mol Imaging Biol; 2020 Aug; 22(4):864-872. PubMed ID: 31792839
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Dissecting the expression landscape of cytochromes P450 in hepatocellular carcinoma: towards novel molecular biomarkers.
    Brodeur CM; Thibault P; Durand M; Perreault JP; Bisaillon M
    Genes Cancer; 2019 May; 10(3-4):97-108. PubMed ID: 31258835
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Significance of PIVKA-II levels for predicting microvascular invasion and tumor cell proliferation in Chinese patients with hepatitis B virus-associated hepatocellular carcinoma.
    Ma XL; Zhu J; Wu J; Tian L; Gao YY; Zhang CY; Zhou Y; Dai Q; Wang BL; Pan BS; Zhou J; Fan J; Yang XR; Guo W
    Oncol Lett; 2018 Jun; 15(6):8396-8404. PubMed ID: 29805574
    [TBL] [Abstract][Full Text] [Related]  

  • 114. An efficient model for auxiliary diagnosis of hepatocellular carcinoma based on gene expression programming.
    Zhang L; Chen J; Gao C; Liu C; Xu K
    Med Biol Eng Comput; 2018 Oct; 56(10):1771-1779. PubMed ID: 29546505
    [TBL] [Abstract][Full Text] [Related]  

  • 115. [Value of detection of serum glypican-3 level in diagnosis and therapeutic effect evaluation of primary hepatocellular carcinoma].
    Wang YY; Zhou CJ; Li J; Zhou L; Li MS; Xiao B
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Aug; 37(8):1060-1065. PubMed ID: 28801286
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Recent advances in hepatocellular carcinoma therapy.
    Dutta R; Mahato RI
    Pharmacol Ther; 2017 May; 173():106-117. PubMed ID: 28174094
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Imaging of HCC-Current State of the Art.
    Schraml C; Kaufmann S; Rempp H; Syha R; Ketelsen D; Notohamiprodjo M; Nikolaou K
    Diagnostics (Basel); 2015 Nov; 5(4):513-45. PubMed ID: 26854169
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Significant biomarkers for the management of hepatocellular carcinoma.
    Kondo Y; Kimura O; Shimosegawa T
    Clin J Gastroenterol; 2015 Jun; 8(3):109-15. PubMed ID: 25855582
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
    Lim TS; Kim DY; Han KH; Kim HS; Shin SH; Jung KS; Kim BK; Kim SU; Park JY; Ahn SH
    Scand J Gastroenterol; 2016 Mar; 51(3):344-53. PubMed ID: 26340708
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance.
    Ismail MM; Morsi HK; Abdulateef NA; Noaman MK; Abou El-Ella GA
    Scand J Clin Lab Invest; 2017 May; 77(3):175-183. PubMed ID: 28276727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.